O Stephan Bancel said Wednesday that his company's coronavirus vaccine "won't be available for widespread distribution until at least spring 2021." Bancel said the drugmaker will not seek emergency FDA authorization approval for its vaccine "until Nov. 25 at the earliest." He added the company would no

//wvvw.foxnews.corn/health/modernas-covid-19-booster-vaccine-promise- against-variants-company-says> (5/5, Rivas, 23.99M) reports on its website that Bancel added, "Our mRNA platform allows for rapid design of vaccine candidates that incorporate key virus mutations, potentially allowing for faster devel

oster strategy should be protective against these newly detected variants." Fox News (5/5, EFTA00135927 Rivas, 23.99M) reports on its website that Bancel added, "Our mRNA platform allows for rapid design of vaccine candidates that incorporate key virus mutations, potentially allowing for faster devel

ce that our booster strategy should be protective against these newly detected variants." Fox News (5/5, Rivas, 23.99M) reports on its website that Bancel added, "Our mRNA platform allows for rapid design of vaccine candidates that incorporate key virus mutations, potentially allowing for faster devel